Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-21-042694 General Corporate
Debt relative to revenue 40th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
126.06% · OPTIONAL · VALID
Capex intensity 13th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.02% · OPTIONAL · VALID
Operating cash generation 47th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.74% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
77.03% · CORE · VALID
Inventory pressure 33th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
53.11% · OPTIONAL · VALID
Gross margin 60th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
23.34% · CORE · VALID
Operating margin 87th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
14.61% · CORE · VALID
R&D intensity 0th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.31% · OPTIONAL · VALID
SBC intensity 73th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.65% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 135.27%
Current 126.06%
Delta -9.21% Capex Intensity Increased
Previous 4.75%
Current 5.02%
Delta 0.27% Cash Generation Increased
Previous 7.72%
Current 7.74%
Delta 0.02% Growth Increased
Previous 18.59%
Current 77.03%
Delta 58.44% Inventory Pressure Increased
Previous 51.78%
Current 53.11%
Delta 1.33% Margin Decreased
Previous 25.42%
Current 23.34%
Delta -2.08% Profitability Decreased
Previous 15.20%
Current 14.61%
Delta -0.59% R And D Intensity Decreased
Previous 1.78%
Current 1.31%
Delta -0.47% Sbc Intensity Decreased
Previous 0.71%
Current 0.65%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.